Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-22

FDA Approved: LETROZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Letrozole from Teva Pharmaceuticals USA, Inc., updating the approved generic product under the ANDA. The approva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

SUPPL AP for LETROZOLE (LETROZOLE)